|1.||Baulard, Alain R: 5 articles (05/2014 - 03/2006)|
|2.||Willand, Nicolas: 3 articles (05/2014 - 04/2012)|
|3.||Deprez, Benoit: 3 articles (05/2014 - 04/2012)|
|4.||Ramachandran, Ranjani: 3 articles (06/2013 - 11/2011)|
|5.||Kumar, Vanaja: 3 articles (06/2013 - 11/2011)|
|6.||Rahman, Fathima: 3 articles (06/2013 - 11/2011)|
|7.||Schaaf, H S: 3 articles (10/2011 - 11/2009)|
|8.||Hesseling, A C: 3 articles (10/2011 - 11/2009)|
|9.||Villemagne, Baptiste: 2 articles (05/2014 - 11/2013)|
|10.||Carette, Xavier: 2 articles (05/2014 - 04/2012)|
11/01/1963 - "[STUDIES ON COMBINED INH-ETHIONAMIDE TREATMENT OF PULMONARY TUBERCULOSIS WITH LOW ETHIONAMIDE DOSAGE]."
12/01/1962 - "[Clinical studies on ethionamide treatment of pulmonary tuberculosis. "
06/01/2013 - "Optimization of the standard proportion sensitivity testing (PST) method for ethionamide was under taken in 235 Mycobacterium tuberculosis isolates from new and previously treated pulmonary tuberculosis patients. "
06/01/1971 - "[Clinical effectiveness of ethionamide in chronic forms of pulmonary tuberculosis in middle-aged and elderly persons]."
09/01/1970 - "A double-blind study to determine the maximum tolerated dose of ethionamide, when administered twice-weekly to patients with pulmonary tuberculosis."
|2.||Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/01/2011 - "Pharmacokinetics and tissue distribution studies of orally administered nanoparticles encapsulated ethionamide used as potential drug delivery system in management of multi-drug resistant tuberculosis."
12/01/2015 - "Ethionamide (ETH) is an antibiotic used for the treatment of multidrug-resistant (MDR) tuberculosis (TB) (MDR-TB), and its use may be limited with the emergence of resistance in the Mycobacterium tuberculosis population. "
12/01/2015 - "Ethionamide, 2-ethylpyridine-4-carbothioamide, is a second-line antituberculosis drug used for the treatment of multidrug-resistant tuberculosis. "
05/01/2012 - "It is, therefore, necessary to revisit the susceptibility testing method for ethionamide for effective clinical management of patients with drug resistant tuberculosis."
10/01/2006 - "Ethionamide is one of the most widely used drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB). "
|3.||Leprosy (Hansen's Disease)
09/01/1966 - "[Value of ethionamide in anti-leprosy therapy]."
10/01/1986 - "In Guadeloupe, from January 1980 to December 1984, 420 leprosy patients were put under daily multidrug therapy: 10 mg/kg RMP plus 100 mg DDS during six months for paucibacillary patients, 10 mg/kg RMP plus 100 mg DDS during 24 months supplemented during the 12 first months with 10 mg/kg of a thioamide, ethionamide or protionamide, for multibacillary patients. "
06/01/1986 - "In multibacillary (MB) leprosy, three regimens were compared: MB-WHO regimen; regimen C, consisting of daily RMP 600 mg, ethionamide (ETH) 500 mg, and DDS or clofazimine (CLO) 100 mg for six months, followed by six months of daily DDS or CLO; and regimen D, identical to regimen C but comprising daily DDS or CLO plus ETH 500 mg during the second semester. "
09/01/1978 - "Further data on the effect of ethionamide and prothionamide in experimental leprosy."
03/01/2006 - "In 1982-1984 we conducted a six-month clinical trial in 50 previously untreated lepromatous leprosy patients randomly assigned to directly observed monotherapy with one of two thioamides, ethionamide or prothionamide, each given six times a week at doses of either 250 mg or 500 mg. The findings of this study have only recently been analyzed, and the potential for the use of these thioamides in leprosy patients placed in perspective. "
12/01/1966 - "[The use of ethionamide in the treatment of primary infection in children]."
03/02/1965 - "[THE PLACE OF ETHIONAMIDE IN THE TREATMENT OF SEVERE PRIMARY INFECTIONS IN CHILDREN AND INFANTS]."
12/01/1963 - "[ETHIONAMIDE IN THE TREATMENT OF PATENT TUBERCULOUS PRIMARY INFECTIONS IN CHILDREN]."
06/01/1984 - "A 42-year-old woman developed goitrous hypothyroidism while receiving ethionamide for treatment of an atypical mycobacterial infection. "
05/01/2014 - "Ethionamide (ETH) is one of the major antitubercular drugs used to treat infections with multidrug-resistant M. "
06/01/1960 - "[Short term study of the treatment of tuberculosis with ethioniamide (Th 1314)]."
05/01/2014 - "EthR is a mycobacterial repressor that limits the bioactivation of ethionamide, a commonly used anti-tuberculosis second-line drug. "
02/01/2012 - "Ethionamide (ETH) is a second-line drug for the treatment of tuberculosis. "
10/01/2011 - "Ethionamide (ETH), a second-line antituberculosis drug, is frequently used in treating childhood tuberculosis. "
07/01/2009 - "To evaluate the presence of ethionamide (ETH) resistance and its effect on time to sputum smear negativity in MDR-TB patients who had not previously received second-line anti-tuberculosis drugs. "
|6.||polylactic acid-polyglycolic acid copolymer (PLGA)
|10.||Aminosalicylic Acid (Rezipas)
|1.||Drug Therapy (Chemotherapy)
|4.||Combination Drug Therapy (Combination Chemotherapy)